These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15317018)

  • 21. Surface characterization of lipid/chitosan nanoparticles assemblies, using X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry.
    Grenha A; Seijo B; Serra C; Remuñán-López C
    J Nanosci Nanotechnol; 2008 Jan; 8(1):358-65. PubMed ID: 18468083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures.
    Garcia-Fuentes M; Alonso MJ; Torres D
    J Colloid Interface Sci; 2005 May; 285(2):590-8. PubMed ID: 15837476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High resolution 1H NMR of a lipid cubic phase using a solution NMR probe.
    Boyle-Roden E; Hoefer N; Dey KK; Grandinetti PJ; Caffrey M
    J Magn Reson; 2007 Nov; 189(1):13-9. PubMed ID: 17855136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
    J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model.
    Kuntsche J; Bunjes H; Fahr A; Pappinen S; Rönkkö S; Suhonen M; Urtti A
    Int J Pharm; 2008 Apr; 354(1-2):180-95. PubMed ID: 17920216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling release from the lipidic cubic phase by selective alkylation.
    Clogston J; Craciun G; Hart DJ; Caffrey M
    J Control Release; 2005 Feb; 102(2):441-61. PubMed ID: 15653163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(2-oxazolines) in biological and biomedical application contexts.
    Adams N; Schubert US
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1504-20. PubMed ID: 17904246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation and properties of reverse micellar cubic liquid crystals and derived emulsions.
    Rodríguez-Abreu C; Shrestha LK; Varade D; Aramaki K; Maestro A; Quintela AL; Solans C
    Langmuir; 2007 Oct; 23(22):11007-14. PubMed ID: 17910486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ternary cubic phases containing ionic liquid.
    Wang Z; Zhou W; Li G
    J Colloid Interface Sci; 2008 Feb; 318(2):405-10. PubMed ID: 17996884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
    Müller RH; Runge SA; Ravelli V; Thünemann AF; Mehnert W; Souto EB
    Eur J Pharm Biopharm; 2008 Mar; 68(3):535-44. PubMed ID: 17804210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ordering of lipid A-monophosphate clusters in aqueous solutions.
    Faunce CA; Reichelt H; Quitschau P; Paradies HH
    J Chem Phys; 2007 Sep; 127(11):115103. PubMed ID: 17887884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of solid lipid nanoparticles in brain targeting.
    Kaur IP; Bhandari R; Bhandari S; Kakkar V
    J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-assembly of polar food lipids.
    Leser ME; Sagalowicz L; Michel M; Watzke HJ
    Adv Colloid Interface Sci; 2006 Nov; 123-126():125-36. PubMed ID: 17045560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
    Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
    Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent.
    Kaasgaard T; Drummond CJ
    Phys Chem Chem Phys; 2006 Nov; 8(43):4957-75. PubMed ID: 17091149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
    Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
    NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.